MEDICAL FACILITIES CORP (DR.CA) Forecast, Price Target & Analyst Ratings

TSX:DRCA58457V5036

Current stock price

16.37 CAD
-0.17 (-1.03%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICAL FACILITIES CORP (DR.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$16.58
+ 1.25% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$1.47
Revenue Estimate
63.86M

ChartMill Buy Consensus

Rating
42.22%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$16.58
Upside
+ 1.25%
From current price of CA$16.37 to mean target of CA$16.58, Based on 9 analyst forecasts
Low
CA$15.66
Median
CA$16.58
High
CA$17.85

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for DR.CA. The average price target is 16.58 CAD. This implies a price increase of 1.25% is expected in the next year compared to the current price of 16.37.

Analyst Ratings & History

Current Analyst Ratings

DR Current Analyst RatingDR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

DR Historical Analyst RatingsDR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
42.22%
DR.CA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about DR.CA.
In the previous month the buy percentage consensus was at a similar level.
DR.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-11-12Leede Jones GabDowngrade Hold
2022-11-11RBC RoyalbankDowngrade Sector Perform
2022-11-11National Bank of Canada FinancialDowngrade
2022-09-15National Bank of Canada FinancialInitiate Sector Perform
2022-05-16RBC RoyalbankDowngrade Sector Perform
2022-05-13National Bank of Canada FinancialDowngrade Sector Perform
2022-03-11RBC RoyalbankUpgrade Sector Perform
2022-03-11National Bank of Canada FinancialUpgrade Outperform
2021-11-12NationalBankFinancialDowngrade Outperform
2021-11-12RBCRoyalBankUpgrade Sector Perform
2021-09-07National Bank FinancialUpgrade Outperform
2021-05-14National Bank FinancialUpgrade Outperform
2021-05-14RBC CapitalUpgrade Sector Perform
2021-03-15RBC CapitalUpgrade Sector Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$1.47
Revenue Estimate
63.86M
Revenue Q2Q
-21.85%
EPS Q2Q
766.41%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-1.53%
EPS (1 Month)
0.00%
EPS (3 Months)
-5.41%

Next Earnings Summary

DR.CA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 1.47 CAD and the consensus revenue estimate is 63.86M CAD.
The next earnings revenue estimate has been revised downward by 1.53% in the past 3 months.

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
DR.CA revenue by date.DR.CA revenue by date.
424.6M
6.52%
339.576M
-20.02%
331.529M
-2.37%
348.33M
5.07%
304.77M
-12.51%
261.52M
-14.19%
264.14M
1.00%
EBITDA
YoY % growth
DR.CA ebitda by date.DR.CA ebitda by date.
82.37M
-9.55%
70.713M
-14.15%
71.316M
0.85%
71.595M
0.39%
58.67M
-18.05%
59.465M
1.36%
57.076M
-4.02%
EBIT
YoY % growth
DR.CA ebit by date.DR.CA ebit by date.
61.6M
-4.20%
49.176M
-20.17%
51.947M
5.63%
N/AN/AN/AN/A
Operating Margin
DR.CA operating margin by date.DR.CA operating margin by date.
14.51%14.48%15.67%N/AN/AN/AN/A
EPS
YoY % growth
DR.CA eps by date.DR.CA eps by date.
0.06
-91.30%
0.68
1,033.33%
0.94
38.24%
1.40
15.96%
1.01
-6.92%
1.07
5.58%
1.22
13.46%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.47
766.41%
0.24
18.45%
0.14
-37.30%
0.26
-47.45%
Revenue
Q2Q % growth
63.86M
-21.85%
66.023M
-18.04%
63.242M
-23.40%
79.104M
5.32%
EBITDA
Q2Q % growth
13.699M
-20.67%
14.111M
-30.35%
11.845M
-51.34%
19.673M
-5.45%
EBIT
Q2Q % growth
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DR.CA Yearly Revenue VS EstimatesDR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DR.CA Yearly EPS VS EstimatesDR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.70%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-8.81%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-6.20%
EBIT Next 5 Year
-5.66%

MEDICAL FACILITIES CORP / DR.CA Forecast FAQ

Can you provide the average price target for MEDICAL FACILITIES CORP stock?

9 analysts have analysed DR.CA and the average price target is 16.58 CAD. This implies a price increase of 1.25% is expected in the next year compared to the current price of 16.37.

Can you provide the upcoming earnings date for MEDICAL FACILITIES CORP?

MEDICAL FACILITIES CORP (DR.CA) will report earnings on 2026-05-06.

Can you provide the consensus estimates for MEDICAL FACILITIES CORP next earnings?

The consensus EPS estimate for the next earnings of MEDICAL FACILITIES CORP (DR.CA) is 1.47 CAD and the consensus revenue estimate is 63.86M CAD.

Can you provide the expected long term growth rate for MEDICAL FACILITIES CORP stock?

The expected long term growth rate for MEDICAL FACILITIES CORP (DR.CA) is -8.81%.